The stock market is down Monday, with the Dow Jones Industrial Average down 0.42%, the Nasdaq down 0.18% and the S&P 500 down 0.43%. Today's winners include a pharmaceutical providing ... Read Full Story »
Everyone, or most everyone, loves initial public offerings and the allure of great gains on the great growth engines of the next decade. Sometimes things just don't work out as ... Read Full Story »
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Alcatel-Lucent (NYSE: ALU) Raised to Neutral at Nomura. Alexion Pharmaceuticals, ... Read Full Story »
Epocrates, Inc. (NASDAQ: EPOC) saw a strong debut so far on Wednesday after its IPO was given a premium price above the range. Yesterday's range was put at $13 to ... Read Full Story »
Epocrates, Inc. (NASDAQ: EPOC) is closer to its IPO. The company offers mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry. The terms have been ... Read Full Story »
Epocrates Inc. submitted an SEC filing to come public via an IPO Thursday night. The filing shows a proposed maximum aggregate offering price of $75 million, although this number is ... Read Full Story »